Interim phase III data show BPL factor X is well tolerated in patients with hereditary FX deficiency March 10, 2014
New mouse model of ulcerative colitis developed to investigate the ileal epithelial barrier March 10, 2014
Phase III results show brexpiprazole to be well tolerated as adjunctive therapy for MDD patients March 7, 2014
Longer-acting clotting factor FVIIa-CTP shows promise, obtains FDA orphan drug designation March 5, 2014
Northern Manhattan Study links markers of infection and neuroendocrine dysfunction with stroke risk March 5, 2014
RSS